Targeting Hepatitis B Virus With CRISPR/Cas9
Hepatitis B virus persistence in infected hepatocytes is due to the presence of covalently closed circular DNA (cccDNA), the template for the transcription of viral RNAs. Antiviral therapies with nucleoside analogues inhibit replication of HBV DNA in capsids present in the cytoplasm of infected cell...
Saved in:
Main Authors: | Christoph Seeger (Author), Ji A Sohn (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
by: Dmitry Kostyushev, et al.
Published: (2023) -
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
by: Xiao-Hui Zhang, et al.
Published: (2015) -
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023) -
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
by: Maren Schiwon, et al.
Published: (2018) -
Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017)